These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32931613)

  • 1. Diagnosis of Chronic Hepatitis B Pericomplication: Risk factors and Trends Over Time.
    Lapointe-Shaw L; Chung H; Holder L; Kwong JC; Sander B; Austin PC; Janssen HLA; Feld JJ
    Hepatology; 2021 Jun; 73(6):2141-2154. PubMed ID: 32931613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis b virus and alcohol].
    Chung NS; Kwon OS; Park CH; Kim YN; Cho GH; Lee JJ; Kim GH; Kim HO; Ko KI; Yu SK; Kwon KA; Kim YS; Choi DJ; Kim JH
    Korean J Gastroenterol; 2007 Jun; 49(6):369-75. PubMed ID: 17641555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What can we learn from hepatitis B virus clinical cohorts?
    Lin CL; Tseng TC; Kao JH
    Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development.
    Samji H; Yu A; Kuo M; Alavi M; Woods R; Alvarez M; Dore GJ; Tyndall M; Krajden M; Janjua NZ;
    J Hepatol; 2017 Nov; 67(5):909-917. PubMed ID: 28684103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.
    Lin CW; Lin CC; Mo LR; Chang CY; Perng DS; Hsu CC; Lo GH; Chen YS; Yen YC; Hu JT; Yu ML; Lee PH; Lin JT; Yang SS
    J Hepatol; 2013 Apr; 58(4):730-5. PubMed ID: 23220252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page?
    Sonneveld MJ; Brouwer WP; de Man RA
    J Hepatol; 2020 Sep; 73(3):728-729. PubMed ID: 32423630
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to: "Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page".
    Chan HL; Wong VW; Yip TC; Wong GL
    J Hepatol; 2020 Sep; 73(3):729-730. PubMed ID: 32423634
    [No Abstract]   [Full Text] [Related]  

  • 8. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
    Lok AS; Perrillo R; Lalama CM; Fried MW; Belle SH; Ghany MG; Khalili M; Fontana RJ; Sterling RK; Terrault N; Feld JJ; Di Bisceglie AM; Lau DTY; Hassan M; Janssen HLA;
    Hepatology; 2021 Jun; 73(6):2124-2140. PubMed ID: 32936969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-complication diagnosis of hepatitis C infection: Risk factors and trends over time.
    Lapointe-Shaw L; Chung H; Sander B; Kwong JC; Holder L; Cerocchi O; Austin PC; Feld JJ
    Liver Int; 2021 Jan; 41(1):33-47. PubMed ID: 32956567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
    Kim EJ; Yeon JE; Kwon OS; Lee HN; Shin SK; Kang SH; Byun KS; Kim JH; Kwon SY; Suh SJ; Yim HJ; Kim YS; Kim JH
    Dig Dis Sci; 2017 Mar; 62(3):808-816. PubMed ID: 28035553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis.
    Goyal SK; Dixit VK; Shukla SK; Ghosh J; Behera M; Tripathi M; Gupta N; Ranjan A; Jain AK
    Indian J Gastroenterol; 2015 Jul; 34(4):286-91. PubMed ID: 26243587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy.
    Zhu DM; Xie J; Ye CY; Qian MY; Xue Y
    Can J Gastroenterol Hepatol; 2020; 2020():8871024. PubMed ID: 33381476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study.
    Kwon OS; Jung YK; Kim YS; Kim SG; Kim YS; Lee JI; Lee JW; Kim YS; Chun BC; Kim JH
    Korean J Hepatol; 2010 Sep; 16(3):308-14. PubMed ID: 20924214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis.
    Tseng TC; Liu CJ; Chang CT; Su TH; Yang WT; Tsai CH; Chen CL; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
    J Hepatol; 2020 Jun; 72(6):1105-1111. PubMed ID: 32006586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus infection in children.
    Komatsu H; Inui A
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):427-50. PubMed ID: 25724218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic hepatitis B].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
    [No Abstract]   [Full Text] [Related]  

  • 19. Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.
    Zeisel MB; Lucifora J; Mason WS; Sureau C; Beck J; Levrero M; Kann M; Knolle PA; Benkirane M; Durantel D; Michel ML; Autran B; Cosset FL; Strick-Marchand H; Trépo C; Kao JH; Carrat F; Lacombe K; Schinazi RF; Barré-Sinoussi F; Delfraissy JF; Zoulim F
    Gut; 2015 Aug; 64(8):1314-26. PubMed ID: 25670809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.